Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

June 28, 2020

Effects of Multiple Schedules of Reinforcement on Appropriate Communication and Challenging Behaviors: A Meta-analysis

Journal of Autism and Developmental Disorders
Reem MuharibStephanie Gerow
July 2, 2020
Open Access

Insights into lncRNAs in Alzheimer's Disease Mechanisms

RNA Biology
Dingfeng LiQiang Liu
June 28, 2020

Zebrafish model of posttraumatic epilepsy

Epilepsia
Sung-Joon ChoAylin Y Reid
July 1, 2020
Review

Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction

Journal of Alzheimer's Disease : JAD
Ernesto SolisErin R Hascup
July 2, 2020

Excess tau PET ligand retention in elderly patients with major depressive disorder

Molecular Psychiatry
Sho MoriguchiMakoto Higuchi
July 1, 2020

Deciphering Alzheimer's disease: predicting new therapeutic strategies via improved understanding of biology and pathogenesis

Expert Opinion on Therapeutic Targets
Rita Khoury, George T Grossberg
June 27, 2020

An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Richard J CaselliGuojun Bu
June 27, 2020
Open Access

Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition

Scientific Reports
Saleha AnwarMd Imtaiyaz Hassan
July 1, 2020
Open Access

HspB5 Activates a Neuroprotective Glial Cell Response in Experimental Tauopathy

Frontiers in Neuroscience
David W HamptonSiddarthan Chandran
June 29, 2020
Preprint

Modeling tau transport in the axon initial segment

ArXiv
I. A. Kuznetsov, A. V. Kuznetsov
June 27, 2020

Targeting pathological tau by small molecule inhibition of the poly(A):MSUT2 RNA-protein interaction

ACS Chemical Neuroscience
Jeremy D BakerBrian C Kraemer
June 27, 2020
Open Access

Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Hye Jin HeoChi Dae Kim
July 1, 2020

Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice

Brain Research Bulletin
Yun CaoXinwen Zhou

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tau-aggregation-genomics/dd022db5-6b6e-48b7-a623-82e481dc12ef